[1]
2025. ASSESSMENT OF ADVERSE EFFECTS OF IMATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS AT CIVIL HOSPITAL OF KARACHI, PAKISTAN. Frontier in Medical and Health Research. 3, 10 (Dec. 2025), 744–748.